Update: Muscle-Invasive Bladder Cancer: AstraZeneca’s Imfinzi Reduced Recurrence And Death
Imfinzi, in combination with chemotherapy, reduces recurrence risk by 32% and death risk by 25% compared to chemotherapy alone for muscle-invasive bladder cancer…